PROTOCOL SUMMARY FOR PATIENTS

View Professional Summary

Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients

Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients


Basic Trial Information

Protocol Phase:Phase I
Study Category:Biomarker/Laboratory analysis
Current Protocol StatusActive
Age18 and over
Protocol SponsorPharmaceutical/Industry
Primary IDA8081012
Other IDNCT01576406
Special Category

TRIAL DESCRIPTION

Purpose:
Eligibility:
Treatment Intervention:
Patient Disclaimer: